EPS for Walgreens Boots Alliance, Inc. (WBA) Expected At $1.26

Keeping an eyeball on Gross profit Margin, Net profit Margin & Operating Margin, the Gross profit margin of 24.70%; the net profit margin of 3.40% while its Operating margin was 4.70% for Walgreens Boots Alliance, Inc. (WBA) share price fell -1.8% to $71.45 in the last trading session.

While looking at the Stock's Performance, Walgreens Boots Alliance, Inc. now shows a Weekly Performance of 1.66%, where Monthly Performance is 6.63%, Quarterly performance is -12.03%, 6 Months performance is -14.31% and yearly performance percentage is -15.16%. State Street Corp now owns 37,612,843 shares of the pharmacy operator's stock valued at $3,123,757,000 after buying an additional 677,743 shares during the period. Hudock Capital Group LLC increased its holdings in shares of Walgreens Boots Alliance by 0.5% in the 2nd quarter. The fund owned 56,100 shares of the pharmacy operator's stock at the end of the first quarter. Finally, Nordea Investment Management AB grew its holdings in Walgreens Boots Alliance by 10.2% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator's stock valued at $107,000 after acquiring an additional 100 shares during the period. As per Thursday, September 1, the company rating was maintained by Credit Suisse. The shares were purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Its quick ratio for the most recent quarter is 0.60. WBA has a Forward P/E ratio of 11.79 with a PEG of 1.23 and a P/S value of 0.6. Coldstream Capital Management Inc. boosted its holdings in shares of Walgreens Boots Alliance by 1.8% in the 1st quarter. (NASDAQ:WBA)'s latest quote $71.57 $0.07 0.17% will find technical support in $70.75 a share and a breakdown below this region would be a significantly bearish signal for Walgreens Boots Alliance, Inc. traders. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to analysts' expectations of $29.93 billion. (NASDAQ:WBA) news were published by: Businesswire.com which released: "Walgreens Boots Alliance Recommends Stockholders Reject Mini-Tender Offer by ..." on November 20, 2017, also Seekingalpha.com with their article: "Walgreens Boots Alliance - Fairly Valued Dividend Aristocrat" published on November 13, 2017, Seekingalpha.com published: "Dividend Aristocrats In Focus Part 47: Walgreens Boots Alliance" on November 22, 2017. The company had Year Ago Sales of $0. Equities analysts forecast that Walgreens Boots Alliance Inc will post $4.97 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. The ex-dividend date of this dividend is Tuesday, May 16th. This represents a $1.60 annualized dividend and a dividend yield of 2.27%. Walgreens Boots Alliance's payout ratio is 39.68%.

Walgreens Boots Alliance announced that its board has approved a share repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

A number of analysts have recently issued reports on the company. Jefferies maintained it with "Buy" rating and $95.0 target in Tuesday, September 5 report. Robert W. Baird restated an "outperform" rating and issued a $96.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, March 27th. Deutsche Bank AG reiterated a "buy" rating and set a $92.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, March 22nd. The firm earned "Hold" rating on Friday, October 13 by SunTrust. (WBA)-7 analysts issued Buy for the stock, 8 analysts gave Outperform rating, 9 think it's a Hold, 0 issued Underperform, while 0 analyst gave a Sell rating.

WBA is now undervalued by -17.02% relative to the average 1-year price target of $86.25 taken from a group of Wall Street Analysts.

In other news, Director William C. Foote sold 2,736 shares of the company's stock in a transaction on Thursday, November 2nd. In a transaction dated October 26, 2017, the shares were bought at an average price of $69.86, giving away a sum of $150,199.

Many value investors look for stocks with a high percent of insider ownership, under the theory that when management are shareholders, they will act in its own self interest, and create shareholder value in the long-term. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Zacks Investment Research upgraded Walgreens Boots Alliance from a "sell" rating to a "hold" rating in a research note on Thursday, March 23rd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now directly owns 50,000 shares of the company's stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Most company stocks have very little volatility.

Following some medium-term indicators on shares of Walgreens Boots Alliance, Inc. Walgreens Boots Alliance presently has a consensus rating of "Buy" and a consensus target price of $86.47. The financial metric shows Walgreens Boots Alliance, Inc. The Company is a global pharmacy-led, health and wellbeing enterprise. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.

Instagram Fights Wildlife Exploitation with New Hashtag Warnings
Amazon.com (NASDAQ:AMZN) Moves On Moffett Nathanson Initiating Coverage of Shares